United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 4, 2026 · Filed May 5, 2026

On May 4, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$576.94 for US$5.77M under a trading plan, leaving 18,876 shares. Filed May 5, 2026 (Form 4).

Sold
10,000 shares
Price
US$576.94 average (US$568.60 to US$582.29)
Value
US$5.77M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockOption exercise10,000US$135.4228,876Direct
May 4, 2026Common StockSale80US$568.6028,796Direct
May 4, 2026Common StockSale80US$570.0628,716Direct
May 4, 2026Common StockSale40US$571.0028,676Direct
May 4, 2026Common StockSale480US$572.4028,196Direct
May 4, 2026Common StockSale153US$573.8228,043Direct
May 4, 2026Common StockSale487US$574.8427,556Direct
May 4, 2026Common StockSale2,436US$575.7525,120Direct
May 4, 2026Common StockSale3,005US$576.6622,115Direct
May 4, 2026Common StockSale719US$577.5421,396Direct
May 4, 2026Common StockSale1,160US$579.1320,236Direct
May 4, 2026Common StockSale440US$580.2619,796Direct
May 4, 2026Common StockSale520US$581.2819,276Direct
May 4, 2026Common StockSale400US$582.2918,876Direct

Source

View original at SEC

Related